Lysergamides
psychedelic, effects to those of the true tryptamines. [1][2][3][4][5][6][7][8][9][10][11][12][13][14][15]
Structure | Name | CAS number | R1 | R6 | R2 | R3 | Other |
---|---|---|---|---|---|---|---|
LAA |
478-94-4 | H | CH3 |
H | H | - | |
DAM-57 |
4238-84-0 | H | CH3 | CH3 | CH3 | - | |
Ergometrine (Ergonovine) | 60-79-7 | H | CH3 | CH(CH3)CH2OH | H | - | |
Ergotamine | 113-15-5 | H | CH3 | -- | C17H18N2O4 | - | |
Methergine |
113-42-8 | H | CH3 | CH(CH2CH3)CH2OH | H | - | |
Methysergide | 361-37-5 | CH3 | CH3 | CH(CH2CH3)CH2OH | H | - | |
Amesergide | 121588-75-8 | CH(CH3)2 | CH3 | C6H11 |
H | - | |
LY-215840 |
137328-52-0 | CH(CH3)2 | CH3 | C5H8OH | H | - | |
Cabergoline | 81409-90-7 | H | H2C=CH-CH2 | CONHCH2CH3 | CH2CH2CH2N(CH3)2 | - | |
LAE-32 | 478-99-9 | H | CH3 | CH2CH3 | H | - | |
LAiP | H | CH3 | CH(CH3)2 | H | - | ||
LAtB | H | CH3 | C(CH3)3 | H | - | ||
LAcB | H | CH3 | (CH2)4 | H | - | ||
Cepentil | H | CH3 | (CH2)5 | H | - | ||
LSB | 137765-82-3 | H | CH3 | CH(CH3)CH2CH3 | H | - | |
LSP | H | CH3 | CH(CH2CH3)CH2CH3 | H | - | ||
DAL | H | CH3 | H2C=CH-CH2 |
H2C=CH-CH2 | - | ||
MIPLA | 100768-08-9 | H | CH3 | CH(CH3)2 |
CH3 | - | |
EIPLA |
H | CH3 | CH(CH3)2 | CH2CH3 | - | ||
ECPLA | H | CH3 | C3H5 | CH2CH3 | - | ||
ETFELA | H | CH3 | CH2CF3 | CH2CH3 | - | ||
LAMPA | 40158-98-3 | H | CH3 | CH2CH2CH3 | CH3 | - | |
EPLA | H | CH2CH3 | CH2CH2CH3 | CH3 | - | ||
LSD / LAD | 50-37-3 | H | CH3 | CH2CH3 | CH2CH3 | - | |
ETH-LAD | 65527-62-0 | H | CH2CH3 | CH2CH3 | CH2CH3 | - | |
PARGY-LAD | H | HC≡C−CH2 |
CH2CH3 | CH2CH3 | - | ||
AL-LAD | 65527-61-9 | H | H2C=CH-CH2 | CH2CH3 | CH2CH3 | - | |
PRO-LAD | 65527-63-1 | H | CH2CH2CH3 |
CH2CH3 | CH2CH3 | - | |
IP-LAD |
H | CH(CH3)2 | CH2CH3 | CH2CH3 | - | ||
CYP-LAD[16] | H | C3H5 |
CH2CH3 | CH2CH3 | - | ||
BU-LAD | 96930-87-9 | H | CH2CH2CH2CH3 |
CH2CH3 | CH2CH3 | - | |
FLUORETH-LAD[17] | H | CH2CH2F | CH2CH3 | CH2CH3 | - | ||
ALD-52 | 3270-02-8 | COCH3 |
CH3 | CH2CH3 | CH2CH3 | - | |
1P-LSD | 2349358-81-0 | COCH2CH3 |
CH3 | CH2CH3 | CH2CH3 | - | |
1B-LSD | 2349376-12-9 | COCH2CH2CH3 | CH3 | CH2CH3 | CH2CH3 | - | |
1V-LSD | CO(CH2)3CH3 | CH3 | CH2CH3 | CH2CH3 | - | ||
1cP-LSD[18] | COC3H5 | CH3 | CH2CH3 | CH2CH3 | - | ||
1D-LSD | COC4H5(CH3)2 | CH3 | CH2CH3 | CH2CH3 | - | ||
1P-AL-LAD | COCH2CH3 | H2C=CH-CH2 | CH2CH3 | CH2CH3 | - | ||
1cP-AL-LAD | COC3H5 | H2C=CH-CH2 | CH2CH3 | CH2CH3 | - | ||
1P-ETH-LAD | COCH2CH3 | CH2CH3 | CH2CH3 | CH2CH3 | - | ||
1P-MIPLA | COCH2CH3 | CH3 | CH(CH3)2 |
CH3 | - | ||
MLD-41 |
4238-85-1 | CH3 | CH3 | CH2CH3 | CH2CH3 | - | |
LSM-775 | 4314-63-0 | H | CH3 | CH2CH2-O-CH2CH2 | - | ||
LPD-824 | 2385-87-7 | H | CH3 | (CH2)4 | - | ||
LSD-Pip | 50485-23-9 | H | CH3 | (CH2)5 | - | ||
LSD-Azapane | H | CH3 | (CH2)6 | - | |||
LA-SS-Az | 470666-31-0 | H | CH3 | CH2(CHCH3)2CH2 | - | ||
2-Bromo-LSD | 478-84-2 | H | CH3 | CH2CH3 | CH2CH3 | 2-Br | |
12-Methoxy-LSD[19] | 50484-99-6 | H | CH3 | CH2CH3 | CH2CH3 | 12-OMe | |
13-Fluoro-LSD[20] | H | CH3 | CH2CH3 | CH2CH3 | 13-F | ||
14-Hydroxy-LSD[21] | H | CH3 | CH2CH3 | CH2CH3 | 14-OH |
See also
- Ergoline
- Bromocriptine
- Fumigaclavine C
- Hydergine
- Lisuride
- Pergolide
References
- PMID 13852489.
- ^ US patent 2997470, Pioch RP, "LYSERGIC ACID AMIDES", published 1956-03-05, issued 1961-08-22
- PMID 4032428.
- S2CID 16490010.
- S2CID 21484356.
- PMID 12213075.
- PMID 17149427.
- PMID 19040555.
- PMID 28401524.
- PMID 26456305.
- PMID 27265891.
- PMID 28342178.
- PMID 28585392.
- PMID 31083768.
- PMID 30298278.
- ^ Kruegel AC. Novel Ergolines and Methods of Treating Mood Disorders. Patent WO 2022/226408
- ^ WO 2022/008627, Grill M, "Improved Method for the Production of Lysergic Acid Diethylamide (LSD) and Novel Derivatives thereof."
- PMID 32180350.
- ^ Usdin E, Efron DH. Psychotropic Drugs and Related Compounds. (1972) ASIN B002X3CDIY
- ^ WO 2021/076572, Olson DE, et al., "Ergoline-like compounds for promoting neural plasticity"
- PMID 31266388.